Find latest DLBCL videos · 100+ videos
University of Colorado Cancer Center
M

Managing R/R LBCL Patients Treated With Pola-R-CHP in 1L and Are CAR-T Ineligible

By University of Colorado Cancer Center FEATURING Manali Kamdar
By University of Colorado Cancer Center FEATURING Manali Kamdar
79 views
November 21, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Related Videos

16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.3K views
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

557 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

453 views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

277 views
20:34

Sequencing of Bispecifics With Other Therapies in DLBCL

UChicago Medicine

E. Budde

336 views
22:35

Lymphoma Hot Topics in 2024: Focus on DLBCL and cHL

Yale Cancer Center

T. Sethi

172 views
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

662 views
06:07

Tafasitamab + Lenalidomide vs. CIT for Transplant-Ineligible R/R DLB…

Patrizia Mondello

177 views
13:07

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Moffitt Cancer Center

J. Chavez

832 views
16:34

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

616 views
18:29

Considering Alternatives to CAR-T in R/R DLBCL

Julio Chavez

152 views
13:57

Tafasitamab/Lenalidomide for DLBCL: Which Patients and What to Expect

Amit Mehta

122 views
25:22

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

100 views
14:47

Bispecifics for LBCL: Guidance for Management of Toxicities in the C…

UChicago Medicine

J. Crombie

163 views
18:15

The Next Frontier of Targeted Therapy in Lymphoma

UChicago Medicine

K. Maddocks

236 views
22:36

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

244 views
30:07

Current Management of DLBCL From Frontline to Relapsed Disease

Dipenkumar Modi

332 views
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

307 views
17:07

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Mana…

2024 ASCO® Annual Meeting Insights Hub

M. Minnema

284 views
40:38

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

246 views
AUTOPLAY